IPO Market — India IPO tracker
Pramodini Medicare logo

Pramodini Medicare IPO

LISTEDSMEPRAMODINI
SME IPO Dashboard →
Share
Save to watchlist

Listing Performance

▲ 1.69%

Issue Price

₹118

Listing Price

₹120

Listed On

19 Aug 2026

Price Band
₹110 – ₹118
Lot Size
1,200
Lot Value
₹1,41,600
Open Date
12 Aug
Close Date
14 Aug
Min Investment
₹1,41,600
Check Pramodini Medicare price on NSE / BSE →

About Pramodini Medicare

Pramodini Medicare Limited is an Indian diagnostic service provider offering a comprehensive range of technology-enabled services, including radiology, clinical laboratory testing, and nuclear medicine. The company serves public and private hospitals, government Public Sector Undertakings (PSUs), and medical colleges across tier I, II, and III cities. Its core offerings are divided into three segments: Radiology (MRI, CT scans, ultrasound), Clinical Laboratory (pathology, microbiology, immunology), and Nuclear Medicine (PET-CT and nuclear therapy). Additionally, it operates a 24×7 teleradiology service from its registered office in Vijayawada. Pramodini Medicare generates revenue by providing routine and specialized tests for prediction, early detection, and disease monitoring. The business uniquely operates across four key models: Public-Private Partnerships (PPP) with government hospitals, Private-Private Partnerships, strategic alliances with PSUs, and standalone private centres. This diversified approach enables the company to deliver widespread preventative and diagnostic healthcare solutions across India.

The company generates revenue through diagnostic testing services provided to government authorities (B2G), corporate/institutional customers (B2B), and individual patients (B2C), with a significant portion derived from government healthcare arrangements.

Employees134
CustomersBOTH
CIN: U85110AP2000PLC035231Registered Office: D. No: - 29-4-54K, CSI Complex, Prakasam Road, Suryaraopet, Vijayawada, Andhra Pradesh, India - 520002Face Value: ₹10www.pramodinidiagnostics.com

Use of IPO Proceeds

Funding of capital expenditure for purchase of Medical Equipments towards Existing and Proposed Diagnostic CentresCapital expenditureby FY27₹45.15 Cr
General corporate purposes and unidentified inorganic acquisitionGeneral corporate purposesby FY27—

Promoters

Dr. Chalasani Kuldeep Kumar

Promoter, Chairman and Managing Director · age 50

Pre-issue: 48.44%

Dr. Chalasani Kavitha

Promoter, Non-Executive Director · age 50

Pre-issue: 9.79%

Ms. Chalasani Durga Aashritha

Promoter, Non-Executive Director · age 21

Investment Analysis

Quick Analysis: 5 strengths · 5 risk factors· Exchange: NSE SME

Strengths (5)

  • •The business model spans PPP, private hospitals, PSUs, and standalone centres.
  • •The diagnostic network grew from 1 centre in FY15 to 16 centres today.
  • •Offers specialized services across radiology, clinical laboratory, and nuclear medicine.
  • •Revenue grew significantly from ₹3,522.95 lakhs in FY24 to ₹6,228.75 lakhs in FY26.
  • •Leverages public health infrastructure through extensive government MOUs.

Risk Factors (5)

  • •High dependence on government PPP MOUs subject to non-renewal or delayed payments.
  • •Focus on capital-intensive radiology exposes the firm to equipment and regulatory risks.
  • •Over 60% revenue concentration in Andhra Pradesh creates geographic risk.
  • •Loss of top institutional clients could severely impair revenue and profitability.
  • •Past statutory filing delays and non-compliances expose the firm to regulatory penalties.

Investor Quota

QIB 50%
NII / HNI 15%
Retail 35%

Approx. shares reserved per category

QIB (50%)29,23,729 shares
NII / HNI (15%)8,77,119 shares
Retail (35%)20,46,610 shares

Estimated from total issue size; actual reserved lots are set in the RHP.

Application Lot Sizes

Retail caps at ₹2,00,000 (1 lots here). S-HNI is ₹2L–₹10L, B-HNI is above ₹10L.

CategoryLotsSharesAmount
Retail (min)11,200₹1,41,600
Retail (max)11,200₹1,41,600
S-HNI (min)22,400₹2,83,200
S-HNI (max)78,400₹9,91,200
B-HNI (min)89,600₹11,32,800

Subscription Status

Overall subscription—(Day 3)
Updated 90 days ago
CategoryDay 1Day 2Day 3
QIB———
sNII (S-HNI)———
bNII (B-HNI)———
Retail———
Total———

Colour: red <1x · amber 1–10x · green ≥10x oversubscribed.

Allotment Statistics

Allotment probability is estimated based on subscription data and is not guaranteed. Actual allotment depends on the registrar's process.

Basis of Allotment

Category-wise subscription & allotment ratio

View →

IPO Timeline

Issue Opens

12 Aug 2026 · Wed

Issue Closes

14 Aug 2026 · Fri

UPI Deadline

14 Aug 2026 · Fri

Allotment

17 Aug 2026 · Mon

Refund

18 Aug 2026 · Tue

Share Credit

18 Aug 2026 · Tue

Listing

19 Aug 2026 · Wed

IPO Details

RegistrarPurva Sharegistry (India) Private Limited
ExchangeNSE SME
ISIN—
Face Value₹10
Issue Size₹69.00 Cr
Fresh Issue—
OFS Size—
Lead ManagersSmart Horizon Capital Advisors Private Limited

3-Year Financial Summary

Revenue trend

↑ FY23→FY25

Fiscal YearRevenue (₹Cr)PAT (₹Cr)EPSP/EROE
FY2538.2410.046.92—30.81%
FY2435.235.76———
FY2330.584.28———

Detailed Line Items (₹ Cr)

Line ItemFY23FY24FY25
EBITDA14.6715.5320.97
Net Worth16.5322.5532.6
Total Borrowings21.3911.9610.81

From the company's offer document (DRHP/RHP); restated figures where available.

Valuation at Issue Price

Issue P/E

17.1x

Price ÷ EPS

EPS (FY25)

₹7

Earnings per share

RoNW

30.81%

Return on net worth

ROCE

39.15%

as reported in filing

EBITDA margin

54.8%

EBITDA ÷ revenue

Price/NAV

6.05x

Price ÷ NAV (as reported)

Check the valuation yourself

Company Fundamentals

11 sections extracted from this filing

Capital Structure

Authorised Capital—
Issued Capital—
Paid-up Capital—
Equity Shares (Pre-Issue)11,61,716
Equity Shares (Post-Issue)1,26,77,370

Source: Pramodini Medicare offer document (DRHP/RHP).

Shareholding Pattern

Pre-Issue

Pre-Issue not disclosed in this filing.Not separately disclosed in Pramodini Medicare's filing.

Post-Issue

  • Promoter+27.83%
  • Promoter+12.57%
  • Promoter+49.67%
  • Promoter+9.92%
  • Promoter+0.00%
Total+99.99%

Source: Pramodini Medicare offer document (DRHP/RHP).

Reservations & OFS

Investor Reservation

  • Anchor60.00%
  • QIB50.00%
  • NII / HNI15.00%
  • Retail35.00%

OFS Selling Shareholders

  • Dr. Chalasani Kuldeep Kumar2,14,400 sh
  • Dr. Chalasani Kavitha1,43,000 sh
  • M/S. Sri Ram Medicare Private Limited1,43,000 sh

Source: Pramodini Medicare offer document (DRHP/RHP).

Board & Management

Board of Directors (6)
  • Dr. Chalasani Kuldeep Kumar₹0.90 Cr p.a.

    Chairman and Managing Director

    Founder and Managing Director of the Company

  • Dr. Chalasani Kavitha₹0.30 Cr p.a.

    Non-Executive Director

  • Ms. Chalasani Durga Aashritha

    Non-Executive Director

  • Dr. Eshwar Chandra Nandury

    Non-Executive Independent Director

  • Mr. Manas Dash

    Non-Executive Independent Director

  • Mr. A Ajay Kumar

    Non-Executive Independent Director

Key Managerial Personnel (3)
  • Dr. Chalasani Kuldeep Kumar₹0.90 Cr p.a.

    Chairman and Managing Director

    Founder and Managing Director

  • Mr. Rushikesh Vijay Gosavi

    Company Secretary and Compliance Officer

    Bachelor of Commerce, Associate Member ICSI

    More than 1 year in corporate governance and statutory compliance

  • Mr. Rajkamal Kona

    Chief Financial Officer

    Master in Commerce

    12 years in accounts and finance

Source: Pramodini Medicare offer document (DRHP/RHP).

Industry & Market

Market Size (TAM)
₹5467022.00 Cr
Growth (CAGR)
+20.00%

Industry figures as stated in Pramodini Medicare's offer document.

Peer Comparison

CompanyP/EEPSRoNW %NAV
Pramodini Medicare Limited—6.9230.8119.52
Invicta Diagnostic Limited14.525.5729.6318.81
Krsnaa Diagnostics Limited25.1524.048.79273.39
Star Imaging & Path Labs Limited6.5811.8233.8434.93

Registrar (RTA)

SEBI-registered Registrar & Transfer Agent — handles allotment and refunds.

Registrar:Purva Sharegistry (India) Private Limited→

Lead Managers (BRLMs)

Click any merchant banker for their full IPO track record (positive listing rate, average gain, IPOs managed).

Documents

Frequently Asked Questions

When is the Pramodini Medicare IPO opening?

The Pramodini Medicare IPO opens on 12 Aug 2026 and closes on 14 Aug 2026. Check this page for the latest updates as we refresh every 30 minutes.

What is the price band of the Pramodini Medicare IPO?

The price band for the Pramodini Medicare IPO is ₹110 to ₹118. The final price is announced after the book-building process and is confirmed before listing.

What is the lot size and minimum investment for the Pramodini Medicare IPO?

The minimum lot size is 1200 shares with a minimum investment of ₹1,41,600. Retail investors can apply for up to the retail limit defined by SEBI.

What is the GMP of Pramodini Medicare IPO today?

Grey Market Premium data for Pramodini Medicare is not available yet. It typically starts appearing a few days before the IPO opens.

When will the Pramodini Medicare IPO list on NSE and BSE?

The Pramodini Medicare IPO is expected to list on 19 Aug 2026 on NSE SME. Actual listing day trading begins at the start of the normal market session.

How can I check the Pramodini Medicare IPO allotment status?

The registrar for this IPO is Purva Sharegistry (India) Private Limited. You can check your allotment status on the registrar's portal using your PAN, application number, or DP ID. We link to the registrar directly on our allotment page after the allotment date.

Is the Pramodini Medicare IPO a mainboard or SME issue?

Pramodini Medicare is a SME IPO that will list on the NSE Emerge or BSE SME platform. SME IPOs require a minimum application value of one lakh rupees.

How do I apply for the Pramodini Medicare IPO?

You can apply for the Pramodini Medicare IPO through any SEBI-registered broker such as Zerodha, Upstox, or Angel One using UPI or ASBA while the issue is open for bidding.

Recently Listed IPOs

CompanyListedListing Gain
Antala Industries11 Nov 2026-20.00%
Vedant Poly Fabs09 Nov 2026+0.00%
Maxwell Engineering Solutions06 Nov 2026+90.00%

Related IPOs

Related Articles

Financial Disclaimer: The information on this page is for educational purposes only and does not constitute investment advice. IPO investments are subject to market risks. Grey Market Premium (GMP) figures are unofficial and not endorsed by SEBI, NSE, or BSE. Past performance is not indicative of future returns. Please read the RHP and consult a SEBI-registered advisor before investing.